ReviewFrontiers in immunology2026
AI-driven radiomics and radiogenomics: supporting the assessment and differentiation of pseudoprogression in cellular immunotherapy for glioblastoma.
Yihua Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.